The Research Progress in Immunotherapy of Tuberculosis
Tuberculosis (TB) is a serious public health problem worldwide. The combination of various anti-TB drugs is mainly used to treat TB in clinical practice. Despite the availability of effective antibiotics, effective treatment regimens still require long-term use of multiple drugs, leading to toxicity...
Enregistré dans:
Auteurs principaux: | Jie Mi, Yan Liang, Jianqin Liang, Wenping Gong, Shuyong Wang, Junxian Zhang, Zhiming Li, Xueqiong Wu |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Frontiers Media S.A.
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/8879e2e53777414da90bd916f9bcabc4 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
The Diversity Outbred Mouse Population Is an Improved Animal Model of Vaccination against Tuberculosis That Reflects Heterogeneity of Protection
par: Sherry L. Kurtz, et autres
Publié: (2020) -
Sputum Smear Non-conversion at the End of Intensive Phase of Tuberculosis Treatment at a Tertiary Center: A Descriptive Cross-sectional study
par: Naveen Prakash Shah, et autres
Publié: (2021) -
Tuberculosis múltiple
par: DANERI N,JULIO
Publié: (1944) -
Colo‐appendico‐duodenal fistula: Rare presentation of extrapulmonary tuberculosis
par: David Eng Yeow Gan, et autres
Publié: (2021) -
Tuberculosis en patrón esporotricoide: una presentación inusual de tuberculosis cutánea en un paciente inmunocompetente
par: Downey,Camila, et autres
Publié: (2015)